Business
Astronics Corporation Reports Record Operating Income on 27% Sales Growth for Second Quarter 2026
Astronics Corporation Reports Record Operating Income on 27% Sales Growth for Second Quarter

About this update from Astronics Corporation
Astronics Corporation (Nasdaq: ATRO) (“Astronics” or the “Company”), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, today reported financial results for the three and six months ended July 4, 2026. Financial results include the acquisition of Bühler Motor Aviation (“BMA”) on October 13, 2025. Peter J. Gundermann, Chairman, President and Chief Executive Officer, commented, “We had a very strong second quarter, with record sales, operating income, bookings and backlog. Our adjusted EBITDA margin of 19.8% was a multi-year high. We see continued strength across our range of markets and products, resulting in another step up in our forecasted 2026 revenue level. We expect momentum to build during the second half of the year. It is an exciting time for our Company.” Second Quarter Results Three Months Ended Six Months Ended ($ in thousands) July 4, 2026 June 28, 2025 % Change July 4, 2026 June 28, 2025 % Change Sales $ 259,957 $ 204,678 27.0 % $ 490,576 $ 410,614 19.5 % Gross profit $ 86,897 $ 52,827 64.5 % $ 162,030 $ 113,676 42.5 % Gross margin 33.4 % 25.8 % 33.0 % 27.7 % Income from operations $ 40,467 $ 4,758 750.5 % $ 67,697 $ 17,895 278.3 % Operating margin % 15.6 % 2.3 % 13.8 % 4.4 % Net income $ 35,060 $ 1,314 2,568.2 % $ 60,600 $ 10,842 458.9 % Net income % 13.5 % 0.6 % 12.4 % 2.6 % Adjusted operating income 2 $ 43,226 $ 18,283 136.4 % $ 72,786 $ 40,902 78.0 % Adjusted operating margin % 2 16.6 % 8.9 % 14.8 % 10.0 % Adjusted net income 2 $ 32,623 $ 13,741 137.4 % $ 55,124 $ 30,714 79.5 % Adjusted EBITDA 2 $ 51,549 $ 25,408 102.9 % $ 89,450 $ 56,147 59.3 % Adjusted EBITDA margin % 2 19.8 % 12.4 % 18.2 % 13.7 % Second Quarter 2026 Results (compared with the prior-year period, unless noted otherwise) Growth in sales was driven by the Aerospace segment’s continued strength in demand primarily from the Commercial Transport market, including $5.9 million from the acquisition of BMA. Aerospace sales increased $43.7 million, or 22.6%, while Test Systems sales grew $11.6 million, or 105.1%. Test Systems sales in the prior year were negatively impacted by $6.4 million due to revisions of estimated costs to complete certain long-term mass transit contracts. Gross profit increased $34.1 million to $86.9 million, or 33.4% of sales, a 760 basis point improvement over the comparator quarter. Gross profit growth and margin expansion were primarily attributable to higher volume, improved productivity, and a $2.0 million IEEPA tariff refund. Prior-year gross profit was negatively impacted by a $5.8 million charge related to Aerospace simplification initiatives and a $6.9 million adverse impact related to a revision of estimated costs to complete certain long-term mass transit contracts in the Test Systems segment. Selling, general and administrative expenses (“SG&A”) decreased $0.9 million. Litigation-related expenses were down $0.9 million, and the prior-year period included a $3.5 million legal fee reimbursement charge relating to the patent infringement dispute in the UK. These decreases were mostly offset by higher wages and benefits, higher incentive-based compensation expenses driven by increased profitability, and incremental expenses related to the acquired BMA business. R&D was down $0.7 million reflecting the timing of projects. Operating margin expanded 1,330 basis points and adjusted operating margin 2 expanded 770 basis points as a result of higher volume and improved productivity in the Aerospace segment and improved performance in the Test Systems segment. Interest expense was down $0.8 million, or 24.7%, on lower rates following the September 2025 refinancing activities. Tax expense in the quarter of $2.8 million reflects the benefits of a partial valuation allowance reversal and research and development costs expected to be expensed. Consolidated net income of $0.75 per diluted share improved from $0.03 per diluted share in the prior-year period from stronger operating profit. Adjusted EBITDA 2 increased 102.9% to $51.5 million, and adjusted EBITDA margin 2 expanded 740 basis points to 19.8% of consolidated sales. Record bookings of $306.2 million in the quarter resulted in a book-to-bill ratio of 1.18:1. For the trailing twelve months, bookings totaled $1.06 billion and the book-to-bill ratio was 1.13:1. Backlog at the end of the quarter was $780.6 million, representing the third consecutive quarter of record backlog. Aerospace Segment Review (compared with the prior-year period, unless noted otherwise) Aerospace segment sales of $237.3 million increased $43.7 million, or 22.6%. Sales in the Commercial Transport market increased $31.4 million, or 21.6%. Growth was primarily related to increased demand for seat motion and inflight entertainment & connectivity (“IFEC”) products. General Aviation sales increased $9.2 million, or 50.3%, to $27.6 million due to higher IFEC product sales of VVIP products. Military Aircraft sales increased $3.2 million, or 11.7%, to $30.6 million from increased sales of flight critical airframe power products. Aerospace segment operating profit of $48.3 million, or 20.3% of sales, improved over the prior-year period reflecting the leverage gained on higher volume, improving production efficiencies, a $2.0 million IEEPA tariff refund, a $4.6 million decrease in litigation-related expenses and legal reserve adjustments related to the UK patent dispute previously discussed, and the absence of a $6.2 million charge for simplification initiatives in the prior-year period. Adjusted Aerospace operating profit 2 increased 61.0% to $50.7 million, or 21.4% of sales, a 510-basis point expansion over the comparator quarter. Aerospace bookings were $243.1 million for a book-to-bill ratio of 1.02:1. During the second quarter, the contract for the current engineering phase of the MV-75 FLRAA program was finalized, which resulted in a booking of $27.4 million. Record backlog for the Aerospace segment was $657.2 million at quarter end. Mr. Gundermann commented, “Our Aerospace business delivered excellent results for the second quarter, achieving record quarterly sales and a 20.3% operating margin. A highlight in the quarter was the finalization of the development contract for the MV-75 FLRAA program, which resulted in a net booking of $27 million. We continue to perform well on that program with expected completion of the development program occurring in mid-2027. Overall, demand for our products remains robust, the team is executing well and we believe we are well positioned for further growth.” Test Systems Segment Review (compared with the prior-year period, unless noted otherwise) Test Systems segment sales of $22.7 million were up $11.6 million from the comparator quarter in 2025. Segment sales in the prior-year period were negatively impacted by a $6.4 million revision of estimated costs to complete certain long-term mass transit contracts, reducing revenue recognized in the period. Test Systems segment operating profit was $0.6 million, compared with an operating loss of $6.7 million in the second quarter of 2025. The revisions to the estimated costs to complete had a $6.9 million detrimental impact to operating income in the prior year. Test Systems profitability continues to be negatively affected by mix and under absorption of fixed costs at current volume levels, as well as approximately $4.1 million of revenue in the current quarter at no margin related to dedicated raw materials for the U.S. Army and U.S. Marine Corps Radio Test Set programs. Margin on that revenue will be recognized through 2026 as production on those programs progress further. Bookings for the Test Systems segment in the quarter were $63.1 million, inclusive of a $44.7 million order from the U.S. Army initiating full rate production for the TS-4549/T Radio Test Sets Program, which is expected to cover deliveries over the next 18 months. The book-to-bill ratio for the quarter was 2.78:1. Backlog for the Test Systems segment was $123.3 million at quarter end. Mr. Gundermann commented, “The big news in the second quarter for our Test business was the first production order for the U.S. Army’s TS-4549/T Radio Test program. Its contribution to our second quarter results was marginal, but the program’s impact will be significant as it ramps up in the coming quarters. This first production order is expected to be followed by similar annual orders in each of the coming four years.” Balance Sheet and Liquidity Cash provided by operations in the second quarter of 2026 was $30.1 million, reflecting higher cash earnings offset by higher working capital requirements, including higher inventory levels to support anticipated revenue growth in the coming quarters. Capital expenditures in the quarter were $5.7 million and $16.9 million year-to-date. Elevated capital expenditures reflect necessary catch-up investments on previously deferred spending as well as the consolidation of operations and capacity improvement in a new Seattle facility. The Company expects to be free cash flow positive for the remainder of the year. Long-term debt decreased $24.1 million to $310.3 million at July 4, 2026, compared with the end of 2025. The Company had available liquidity of $253.2 million at quarter-end, including $15.4 million in available cash and $237.8 million in availability on its revolver. Update on Favorable Appeal Ruling from UK Court of Appeal As previously announced, a favorable judgment was issued on July 27, 2026, by the United Kingdom Court of Appeal regarding the Company’s long-running patent infringement dispute with Lufthansa Technik AG. The Company’s position is that approximately $2.2 million (including interest) of the damages paid by the Company to Lufthansa is due to be repaid to the Company. The Company also expects to be reimbursed for a portion its legal fees and those previously paid to Lufthansa, but the amount cannot be estimated at this time. Any reimbursements will be recorded when received, which is expected to be in the third quarter of 2026. 2026 Outlook Astronics expects to set another annual sales record in 2026 with revenue estimated to be $1.02 billion to $1.04 billion for the year, with third quarter sales of $265 million to $275 million. Record backlog at the end of the second quarter was $780.6 million, of which approximately 82% is expected to drive revenue over the next twelve months. Mr. Gundermann concluded, “We expect to set yet another quarterly sales record in the third quarter, with revenue in the fourth quarter to improve modestly from there. Given our record backlog and the continued strength in our order book, we believe we are well situated to deliver growth for the foreseeable future.” Planned capital expenditures in 2026 are expected to be in the range of $40 million to $45 million driven largely by costs associated with the Seattle operation consolidation, which will conclude in the third quarter. The Company estimates future IEEPA tariff refunds will range from $6 million to $8 million although the timing of such receipts cannot be confirmed at this time. Second Quarter 2026 Webcast and Conference Call The Company will host a teleconference today at 4:45 p.m. ET. During the teleconference, management will review the financial and operating results for the period and discuss Astronics’ corporate strategy and outlook. A question-and-answer session will follow. The Astronics conference call can be accessed by calling (201) 493-6784. The listen-only audio webcast can be monitored at investors.astronics.com . To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13761059. The telephonic replay will be available from 8:00 p.m. on the day of the call through Tuesday, August 25, 2026. The webcast replay can be accessed via the investor relations section of the Company’s website where a transcript will also be posted once available. About Astronics Corporation Astronics Corporation (Nasdaq: ATRO) serves the world’s aerospace, defense, and other mission-critical industries with proven innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, military branches, completion centers, and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company’s strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets. Safe Harbor Statement This news release contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words “expect,” “anticipate,” “plan,” “may,” “will,” “estimate,” “feeling” or other similar expressions and include all statements with regard to the Company’s 2026 outlook including record annual and quarterly sales, the level of activity in the second half of 2026, the strength of the Company’s market position and product demand as well as any level of growth into the foreseeable future, operating leverage gained on higher volume and resulting profitability, the significance of the U.S. Army Radio Test Set program to results, any future potential orders and the rate and level of sales growth and profitability improvement in the Test segment related to ramping the program up to full rate production, the amount of reimbursement related to the favorable UK award for the intellectual property case and the amount of tariff refunds to be received. The forward-looking statements also include all statements related to achieving any revenue or profitability expectations, expectations of continued growth, the level of liquidity, the level of cash generation and free cash flow, the level of demand by customers and markets and the amount of expected capital expenditures, the amount of investment in an ERP system, the amount of backlog to be recognized as revenue over the next twelve months, statements regarding the amount of opportunities available to be executed and the effectiveness of the Company’s execution in its operations. Because such statements apply to future events, they are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. Important factors that could cause actual results to differ materially from what may be stated here include the trend in growth with passenger power and connectivity on airplanes, the state of the aerospace and defense industries, commercial aircraft build rates, the market acceptance of newly developed products, internal production capabilities, the timing of orders received, the status of customer certification processes and delivery schedules, the demand for and market acceptance of new or existing aircraft which contain the Company’s products, the impact of regulatory activity, the need for new and advanced test equipment, customer preferences and relationships, the effectiveness of the Company’s supply chain and execution on opportunities, and other factors which are described in filings by Astronics with the Securities and Exchange Commission. Except as required by applicable law, the Company assumes no obligation to update forward-looking information in this news release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise. Use of Non-GAAP Financial Metrics and Additional Financial Information In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Astronics provides Adjusted Non-GAAP information as additional information for its operating results. References to Adjusted Non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. Astronics management uses these measures for reviewing the financial results of Astronics for budget planning purposes and for making operational and financial decisions. Management believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate Astronics core operating and financial performance and business trends consistent with how management evaluates such performance and trends. FINANCIAL TABLES FOLLOW ASTRONICS CORPORATION CONSOLIDATED STATEMENT OF OPERATIONS DATA (Unaudited, $ in thousands except per share amounts) Three Months Ended Six Months Ended 7/4/2026 6/28/2025 7/4/2026 6/28/2025 Sales $ 259,957 $ 204,678 $ 490,576 $ 410,614 Cost of products sold 173,060 151,851 328,546 296,938 Gross profit 86,897 52,827 162,030 113,676 Gross margin 33.4 % 25.8 % 33.0 % 27.7 % Research and development expenses 10,869 11,572 22,958 22,639 Selling, general and administrative 35,561 36,497 71,375 73,142 SG&A % of sales 13.7 % 17.8 % 14.5 % 17.8 % Income from operations 40,467 4,758 67,697 17,895 Operating margin 15.6 % 2.3 % 13.8 % 4.4 % Other expense (income) 281 (190 ) 390 (377 ) Interest expense, net 2,332 3,097 4,668 6,247 Income before tax 37,854 1,851 62,639 12,025 Income tax expense 2,794 537 2,039 1,183 Net income $ 35,060 $ 1,314 $ 60,600 $ 10,842 Net income % of sales 13.5 % 0.6 % 12.4 % 2.6 % Basic earnings per share: 3 $ 0.82 $ 0.03 $ 1.41 $ 0.26 Diluted earnings per share: 3, 4 $ 0.75 $ 0.03 $ 1.31 $ 0.25 Weighted average diluted shares outstanding (in thousands) 3, 4 46,535 43,641 46,219 43,271 ASTRONICS CORPORATION CONSOLIDATED BALANCE SHEETS ($ in thousands) (unaudited) 7/4/2026 12/31/2025 ASSETS Cash and cash equivalents $ 9,016 $ 18,180 Accounts receivable, net of allowance for estimated credit losses 228,900 204,672 Inventories 220,065 196,860 Prepaid expenses and other current assets 27,763 18,027 Total current assets 485,744 437,739 Property, plant and equipment, net of accumulated depreciation 115,568 107,078 Operating right-of-use assets 31,273 32,269 Other assets 14,366 11,316 Intangible assets, net of accumulated amortization 49,392 55,353 Goodwill 64,501 62,923 Total assets $ 760,844 $ 706,678 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable $ 64,399 $ 41,080 Current operating lease liabilities 5,930 5,802 Accrued expenses and other current liabilities 66,462 68,324 Customer advances and deferred revenue 26,589 26,069 Total current liabilities 163,380 141,275 Long-term debt 310,319 334,451 Long-term operating lease liabilities 36,717 38,101 Other liabilities 52,208 52,777 Total liabilities 562,624 566,604 Shareholders’ equity: 5 Common stock 457 456 Accumulated other comprehensive loss (6,108 ) (4,410 ) Other shareholders’ equity 203,871 144,028 Total shareholders’ equity 198,220 140,074 Total liabilities and shareholders’ equity $ 760,844 $ 706,678 ASTRONICS CORPORATION CONSOLIDATED CASH FLOWS DATA Six Months Ended (Unaudited, $ in thousands) 7/4/2026 6/28/2025 Cash flows from operating activities: Net income $ 60,600 $ 10,842 Adjustments to reconcile net income to cash from operating activities: Non-cash items: Depreciation and amortization 12,235 10,966 Amortization of deferred financing fees 1,204 1,214 Provisions for non-cash losses on inventory and receivables 3,257 2,941 Equity-based compensation expense 4,819 3,902 Deferred tax expense (benefit) 1,022 (1,125 ) Operating lease non-cash expense 2,806 3,174 Simplification initiative-related non-cash charges — 6,229 Other 1,223 (601 ) Cash flows from changes in operating assets and liabilities: Accounts receivable (24,997 ) 5,803 Inventories (27,500 ) (1,498 ) Accounts payable 23,620 2,957 Operating lease liabilities (3,093 ) (2,302 ) Accrued expenses (1,929 ) (17,064 ) Income taxes (1,128 ) (10,505 ) Cloud computing implementation costs (4,122 ) — Customer advance payments and deferred revenue 478 (859 ) Supplemental retirement plan liabilities (367 ) (202 ) Other assets and liabilities (7,403 ) (864 ) Net cash provided by operating activities 40,725 13,008 Cash flows from investing activities: Capital expenditures (16,869 ) (6,710 ) Net cash used by investing activities (16,869 ) (6,710 ) Cash flows from financing activities: Proceeds from long-term debt 40,000 1,143 Principal payments on long-term debt (65,000 ) (11,143 ) Financing-related costs — (740 ) Stock award activity (5,441 ) (1,730 ) Other (2,220 ) (76 ) Net cash used by financing activities (32,661 ) (12,546 ) Effect of exchange rates on cash (359 ) 1,280 Decrease in cash and cash equivalents and restricted cash (9,164 ) (4,968 ) Cash and cash equivalents and restricted cash at beginning of period 18,180 18,428 Cash and cash equivalents and restricted cash at end of period $ 9,016 $ 13,460 Supplemental disclosure of cash flow information Capital expenditures in accounts payable (non-cash investing activities) $ 422 $ — Interest paid $ 3,972 $ 2,967 Income taxes paid, net $ 2,110 $ 12,848 ASTRONICS CORPORATION SEGMENT SALES AND PROFIT (Unaudited, $ in thousands) Three Months Ended Six Months Ended 7/4/2026 6/28/2025 7/4/2026 6/28/2025 Sales Aerospace $ 237,292 $ 193,647 $ 451,135 $ 385,035 Less inter-segment — (21 ) (23 ) (34 ) Total Aerospace 237,292 193,626 451,112 385,001 Test Systems 22,674 11,341 39,498 25,933 Less inter-segment (9 ) (289 ) (34 ) (320 ) Total Test Systems 22,665 11,052 39,464 25,613 Total consolidated sales 259,957 204,678 490,576 410,614 Segment gross profit and margins Aerospace 82,152 54,891 152,845 113,374 34.6 % 28.3 % 33.9 % 29.4 % Test Systems 4,745 (2,064 ) 9,185 302 20.9 % (18.7 )% 23.3 % 1.2 % Total gross profit 86,897 52,827 162,030 113,676 33.4 % 25.8 % 33.0 % 27.7 % Segment operating profit and margins Aerospace 48,264 18,039 83,596 40,303 20.3 % 9.3 % 18.5 % 10.5 % Test Systems 592 (6,710 ) 995 (8,933 ) 2.6 % (60.7 )% 2.5 % (34.9 )% Total segment operating profit 48,856 11,329 84,591 31,370 Interest expense 2,332 3,097 4,668 6,247 Corporate expenses and other 8,670 6,381 17,284 13,098 Income before taxes $ 37,854 $ 1,851 $ 62,639 $ 12,025 ASTRONICS CORPORATION SALES BY MARKET (Unaudited, $ in thousands) Three Months Ended Six Months Ended 2026 YTD 7/4/2026 6/28/2025 % Change 7/4/2026 6/28/2025 % Change % of Sales Aerospace Segment Commercial Transport $ 177,006 $ 145,573 21.6 % $ 333,425 $ 283,115 17.8 % 68.0 % Military Aircraft 30,631 27,433 11.7 % 64,133 60,696 5.7 % 13.1 % General Aviation 27,603 18,370 50.3 % 49,052 33,613 45.9 % 10.0 % Other 2,052 2,250 (8.8 )% 4,502 7,577 (40.6 )% 0.9 % Aerospace Total 237,292 193,626 22.6 % 451,112 385,001 17.2 % 92.0 % Test Systems Segment Government & Defense 22,665 11,052 105.1 % 39,464 25,613 54.1 % 8.0 % Total Sales $ 259,957 $ 204,678 27.0 % $ 490,576 $ 410,614 19.5 % SALES BY PRODUCT LINE 6 (Unaudited, $ in thousands) Three Months Ended Six Months Ended Recast Recast 2026 YTD 7/4/2026 6/28/2025 % Change 7/4/2026 6/28/2025 % Change % of Sales Aerospace Segment Inflight Entertainment & Connectivity $ 126,008 $ 105,902 19.0 % $ 236,756 $ 209,012 13.3 % 48.3 % Lighting & Safety 59,170 56,100 5.5 % 111,977 108,057 3.6 % 22.8 % Flight Critical Electrical Power 23,660 15,832 49.4 % 48,423 37,146 30.4 % 9.9 % Seat Motion 22,186 10,217 117.1 % 42,065 16,889 149.1 % 8.6 % Other 6,268 5,575 12.4 % 11,891 13,897 (14.4 )% 2.4 % Aerospace Total 237,292 193,626 22.6 % 451,112 385,001 17.2 % 92.0 % Test Systems 22,665 11,052 105.1 % 39,464 25,613 54.1 % 8.0 % Total $ 259,957 $ 204,678 27.0 % $ 490,576 $ 410,614 19.5 % ASTRONICS CORPORATION ORDER AND BACKLOG TREND (Unaudited, $ in thousands) Q3 2025 Q4 2025 Q1 2026 Q2 2026 Trailing Twelve Months 9/27/2025 12/31/2025 4/4/2026 7/4/2026 7/4/2026 Sales Aerospace $ 192,725 $ 219,593 $ 213,820 $ 237,292 $ 863,430 Test Systems 18,722 20,474 16,799 22,665 78,660 Total Sales $ 211,447 $ 240,067 $ 230,619 $ 259,957 $ 942,090 Bookings Aerospace $ 191,859 $ 237,327 $ 264,381 $ 243,140 $ 936,707 Test Systems 18,532 19,902 26,067 63,051 127,552 Total Bookings $ 210,391 $ 257,229 $ 290,448 $ 306,191 $ 1,064,259 Backlog 7 Aerospace $ 572,459 $ 600,803 $ 651,364 $ 657,212 Test Systems 74,264 73,692 82,960 123,346 Total Backlog $ 646,723 $ 674,495 $ 734,324 $ 780,558 N/A Book:Bill Ratio Aerospace 1.00 1.08 1.24 1.02 1.08 Test Systems 0.99 0.97 1.55 2.78 1.62 Total Book:Bill 1.00 1.07 1.26 1.18 1.13 ASTRONICS CORPORATION RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (Unaudited, $ in thousands) Consolidated Three Months Ended Six Months Ended 7/4/2026 6/28/2025 7/4/2026 6/28/2025 Net income $ 35,060 $ 1,314 $ 60,600 $ 10,842 Add back: Interest expense 2,332 3,097 4,668 6,247 Income tax expense 2,794 537 2,039 1,183 Depreciation and amortization expense 6,341 5,378 12,235 10,966 Equity-based compensation expense 2,263 1,557 4,819 3,902 Simplification and restructuring initiatives — 6,229 — 6,508 ERP implementation consulting expenses 482 — 656 — Legal reserve, settlements and recoveries — 3,504 — 9,732 Litigation-related legal expenses 1,871 2,753 3,650 5,728 Acquisition-related expenses — — 186 — Warranty reserve 406 1,039 597 1,039 Adjusted EBITDA $ 51,549 $ 25,408 $ 89,450 $ 56,147 Sales $ 259,957 $ 204,678 $ 490,576 $ 410,614 Adjusted EBITDA margin % 19.8 % 12.4 % 18.2 % 13.7 % Adjusted EBITDA is defined as net income before interest expense, income taxes, depreciation, amortization, and other adjustments. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by sales. Adjusted EBITDA and Adjusted EBITDA Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted EBITDA and Adjusted EBITDA Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted EBITDA and Adjusted EBITDA Margin, are important for investors and other readers of the Company’s financial statements. ASTRONICS CORPORATION RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT (Unaudited, $ in thousands) Consolidated Three Months Ended Six Months Ended 7/4/2026 6/28/2025 7/4/2026 6/28/2025 Gross profit $ 86,897 $ 52,827 $ 162,030 $ 113,676 Add back: Restructuring-related charges including severance — 5,807 — 5,807 Warranty reserve 406 1,039 597 1,039 Adjusted gross profit $ 87,303 $ 59,673 $ 162,627 $ 120,522 Sales $ 259,957 $ 204,678 $ 490,576 $ 410,614 Gross Margin 33.4 % 25.8 % 33.0 % 27.7 % Adjusted gross margin 33.6 % 29.2 % 33.2 % 29.4 % Adjusted Gross Profit is defined as gross profit as reported, adjusted for certain items. Adjusted Gross Profit Margin is defined as Adjusted Gross Profit divided by sales. Adjusted Gross Profit and Adjusted Gross Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Gross Profit and Adjusted Gross Profit Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Gross Profit and Adjusted Gross Profit Margin, are important for investors and other readers of the Company’s financial statements and assists in understanding the comparison of the current quarter’s and current year’s gross profit and gross profit margin to the historical periods’ gross profit, as well as facilitates a more meaningful comparison of the Company’s gross profit and gross profit margin to that of other companies. ASTRONICS CORPORATION RECONCILIATION OF OPERATING INCOME TO ADJUSTED OPERATING INCOME (Unaudited, $ in thousands) Consolidated Three Months Ended Six Months Ended 7/4/2026 6/28/2025 7/4/2026 6/28/2025 Income from operations $ 40,467 $ 4,758 $ 67,697 $ 17,895 Add back: Restructuring-related charges including severance — 6,229 — 6,508 ERP implementation consulting expenses 482 — 656 — Legal reserve, settlements and recoveries — 3,504 — 9,732 Litigation-related legal expenses 1,871 2,753 3,650 5,728 Acquisition-related expenses — — 186 — Warranty reserve 406 1,039 597 1,039 Adjusted operating income $ 43,226 $ 18,283 $ 72,786 $ 40,902 Sales $ 259,957 $ 204,678 $ 490,576 $ 410,614 Operating margin 15.6 % 2.3 % 13.8 % 4.4 % Adjusted operating margin 16.6 % 8.9 % 14.8 % 10.0 % Adjusted Operating Income is defined as income from operations as reported, adjusted for certain items. Adjusted Operating Margin is defined as Adjusted Operating Income divided by sales. Adjusted Operating Income and Adjusted Operating Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Operating Income and Adjusted Operating Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Operating Income and Adjusted Operating Margin, are important for investors and other readers of the Company’s financial statements and assists in understanding the comparison of the current periods’ income from operations to the historical periods’ income from operations and operating margin, as well as facilitates a more meaningful comparison of the Company’s income from operations and operating margin to that of other companies. ASTRONICS CORPORATION RECONCILIATION OF NET INCOME AND DILUTED EARNINGS PER SHARE TO ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER SHARE (Unaudited, $ in thousands except per share amounts) Consolidated Three Months Ended Six Months Ended 7/4/2026 6/28/2025 7/4/2026 6/28/2025 Net income $ 35,060 $ 1,314 $ 60,600 $ 10,842 Add back (deduct): Amortization of intangibles 2,884 2,945 5,771 5,920 Simplification and restructuring initiatives — 6,229 — 6,508 ERP implementation consulting expenses 482 — 656 — Legal reserve, settlements and recoveries — 3,504 — 9,732 Litigation-related legal expenses 1,871 2,753 3,650 5,728 Acquisition-related expenses — — 186 — Warranty reserve 406 1,039 597 1,039 Normalize tax rate 8 (8,080 ) (4,043 ) (16,336 ) (9,055 ) Adjusted net income $ 32,623 $ 13,741 $ 55,124 $ 30,714 Weighted average diluted shares outstanding (in thousands) 9,10 46,535 43,641 46,219 43,271 Diluted earnings per share 9,10 $ 0.75 $ 0.03 $ 1.31 $ 0.25 Adjusted diluted earnings per share 9,10 $ 0.70 $ 0.31 $ 1.19 $ 0.71 Adjusted Net Income and Adjusted Diluted EPS are defined as net income and diluted EPS as reported, adjusted for certain items, including amortization of intangibles, and also adjusted for a normalized tax rate. Adjusted Net Income and Adjusted Diluted EPS are not measures determined in accordance with GAAP and may not be comparable with the measures used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Net Income and Adjusted Diluted EPS, are important for investors and other readers of the Company’s financial statements and assists in understanding the comparison of the current periods’ net income and diluted EPS to the historical periods’ net income and diluted EPS, as well as facilitates a more meaningful comparison of the Company’s net income and diluted EPS to that of other companies. The Company believes that presenting Adjusted Diluted EPS provides a better understanding of its earnings power inclusive of adjusting for the non-cash amortization of intangible assets, reflecting the Company’s strategy to grow through acquisitions as well as organically. ASTRONICS CORPORATION RECONCILIATION OF SEGMENT OPERATING PROFIT (LOSS) TO ADJUSTED SEGMENT OPERATING PROFIT (LOSS) (Unaudited, $ in thousands) Three Months Ended Six Months Ended 7/4/2026 6/28/2025 7/4/2026 6/28/2025 Aerospace operating profit $ 48,264 $ 18,039 $ 83,596 $ 40,303 Simplification and restructuring initiatives — 6,229 — 6,508 ERP implementation consulting expenses 482 — 656 — Legal reserve, settlements and recoveries — 3,504 — 9,732 Litigation-related legal expenses 1,556 2,676 3,067 4,920 Warranty reserve 406 1,039 597 1,039 Adjusted Aerospace operating profit $ 50,708 $ 31,487 $ 87,916 $ 62,502 Aerospace sales $ 237,292 $ 193,626 $ 451,112 $ 385,001 Aerospace margin 20.3 % 9.3 % 18.5 % 10.5 % Adjusted Aerospace margin 21.4 % 16.3 % 19.5 % 16.2 % Test Systems operating profit (loss) $ 592 $ (6,710 ) $ 995 $ (8,933 ) Litigation-related legal expenses 112 77 160 808 Adjusted Test Systems operating profit (loss) $ 704 $ (6,633 ) $ 1,155 $ (8,125 ) Test Systems sales $ 22,665 $ 11,052 $ 39,464 $ 25,613 Test Systems margin 2.6 % (60.7 )% 2.5 % (34.9 )% Adjusted Test Systems margin 3.1 % (60.0 )% 2.9 % (31.7 )% Adjusted Segment Operating Profit is defined as segment operating profit as reported, adjusted for certain items. Adjusted Segment Margin is defined as Adjusted Segment Operating Profit divided by segment sales. Adjusted Segment Operating Profit and Adjusted Segment Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Segment Operating Profit and Adjusted Segment Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Segment Operating Profit and Adjusted Segment Margin, are important for investors and other readers of the Company’s financial statements and assists in understanding the comparison of the current periods’ segment operating profit to the historical periods’ segment operating profit and segment margin, as well as facilitates a more meaningful comparison of the Company’s segment operating profit and segment margin to that of other companies. 1 Adjusted EBITDA, adjusted EBITDA margin, and adjusted segment operating margin are Non-GAAP financial measures. Please see the reconciliation of GAAP to non-GAAP financial measures in the tables that accompany this release. 2 Adjusted operating income, adjusted operating margin, adjusted segment operating profit and margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income and adjusted diluted earnings per share (“EPS”) are Non-GAAP financial measures. Please see the reconciliation of GAAP to non-GAAP financial measures in the tables that accompany this release. 3 All share and per share information have been adjusted to reflect the impact of the twenty percent Class B stock distribution to shareholder of record on June 15, 2026. 4 In addition to incremental shares from stock awards, weighted-average diluted shares for the three and six months ended July 4, 2026 include 1.708 million and 1.492 million assumed shares, respectively, related to the premium on the 0% convertible notes, as the Company’s average stock price during the periods exceeded the $45.19 per‑share conversion price (as adjusted for the twenty percent Class B stock distribution). Because of the capped call, there is no effective dilution to shareholders from the 0% convertible notes unless and until the share price exceeds $68.44 per-share cap price. The diluted EPS calculation for the three and six months ended July 4, 2026 and June 28, 2025 excludes the effect of the 5.5% convertible notes because they are anti-dilutive for those periods. 5 Prior-period Shareholders’ Equity balances have been adjusted to reflect the impact of the twenty percent Class B stock distribution to shareholders of record on June 15, 2026, with no impact on Total Shareholders’ Equity. 6 Beginning in the first quarter of 2026, the Company reorganized its product line structure to align with changes in internal reporting. The Company recast the prior-year disaggregation of sales by product line to conform with the updated, current-period presentation. 7 Aerospace backlog of approximately $2.4 million and $10.6 million was added in the third and fourth quarters of 2025, respectively, in connection with the acquisitions of Envoy Aerospace and Bühler Motor Aviation. 8 Applies a normalized tax rate of 25% to GAAP pre-tax income and non-GAAP adjustments above, which are each pre-tax. 9 All share and per share information have been adjusted to reflect the impact of the twenty percent Class B stock distribution to shareholders of record on June 15, 2026. 10 In addition to incremental shares from stock awards, weighted-average diluted shares for the three and six months ended July 4, 2026 include 1.708 million and 1.492 million assumed shares, respectively, related to the premium on the 0% convertible notes, as the Company’s average stock price during the periods exceeded the $45.19 per‑share conversion price (as adjusted for the twenty percent Class B stock distribution). Because of the capped call, there is no effective dilution to shareholders from the 0% convertible notes unless and until the share price exceeds $68.44 per-share cap price. The diluted EPS calculation for the three and six months ended July 4, 2026 and June 28, 2025 excludes the effect of the 5.5% convertible notes because they are anti-dilutive for those periods. View source version on businesswire.com: https://www.businesswire.com/news/home/20260811327734/en/
View stock analysis, news, and events for Astronics Corporation